Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
Zoë R GreenwaldLina N HuangMichel D WissingEduardo L FrancoWalter H GotliebPublished in: Cancer (2016)
Based on this population-based cohort, young patients with low-grade endometrial cancer appear to have excellent survival, regardless of the primary therapy chosen (HT vs primary surgery). The current selection of patients for HT to preserve fertility, which is managed carefully by experienced clinicians, does not appear to significantly worsen clinical outcomes. Cancer 2017;123:1545-1554. © 2017 American Cancer Society.
Keyphrases
- endometrial cancer
- low grade
- early stage
- papillary thyroid
- childhood cancer
- end stage renal disease
- high grade
- squamous cell
- minimally invasive
- newly diagnosed
- ejection fraction
- chronic kidney disease
- palliative care
- peritoneal dialysis
- prognostic factors
- free survival
- lymph node metastasis
- squamous cell carcinoma
- coronary artery disease
- young adults
- patient reported outcomes
- type diabetes
- skeletal muscle
- middle aged
- adipose tissue
- atrial fibrillation
- polycystic ovary syndrome
- acute coronary syndrome
- lymph node
- sentinel lymph node
- rectal cancer
- percutaneous coronary intervention